iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th
NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September 30, 2018 after the close of the market and host a conference call at 4:30pm Eastern Time on Tuesday, November 13th.
Tuesday, November 13th@ 4:30pm Eastern Time Domestic: 888-599-8686 International: 323-994-2093 Conference ID: 1529049 Webcast: http://public.viavid.com/index.php?id=131972 Replays available through November 27th: Domestic: 844-512-2921 International: 412-317-6671 Replay PIN: 1529049
In addition, a replay of the call will remain on the Company’s website ( www.icadmed.com ) until the Company releases its fourth quarter and year ended 2018 financial results.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Media Inquiries:ARPR, on behalf of iCAD, Inc.Paul Barren(855) 300-8209 firstname.lastname@example.org
Investor Relations:LifeSci AdvisorsJeremy Feffer(212) 915-2568 email@example.com